Lawrence Toll, Ph.D., a renowned scientist whose research focuses on the management of pain and drug addiction through pharmacology and new drug discovery, recently joined FAU.
A researcher from the Schmidt College of Medicine is conducting a novel study to figure out if there is a unique genetic signature of patients who are most susceptible to prescription opioid-use disorder.
Randy Blakely, Ph.D. and Amy Wright, Ph.D. have been named NAI Fellows.
FAU has received a $1.3 million NIH grant for a "living" robot with its own nervous system. Researchers are creating a living pathway from the robot's touch sensation to the user's brain to help amputees.
A new study finds that the majority of hospice providers don't have end-of-life wishes themselves. Procrastination, fear of the subject and costs were reported as the most common barriers.
FAU's Charles E. Schmidt College of Medicine hosted a ribbon-cutting ceremony to observe the official launch of its newly expanded, 15,000-square-foot, state-of-the-art Clinical Skills Simulation Center.
The first economic study on frontotemporal degeneration (FTD), the most common dementia for people under age 60, shows that FTD inflicts a much more severe burden on families than Alzheimer's disease.
The "Dementia Prevention Initiative" abandons generalized methods used to research and treat Alzheimer's disease. The secret weapon: a novel "N-of-1 design" that personalizes medicine down to a single patient.
A $2.3 million National Institutes of Health grant will help FAU neuroscientists to continue research to better understand and treat several neuropsychiatric disorders including depression and autism.
By combining microbiology with engineering technologies, researchers are developing a novel 3D model to study malaria-infected placenta, and have received a $400,000 NIH grant to develop this microsensor.